Quoted:
In at least 30 studies of lipid-lowering medications, there was no association between these medications and dementia risk. “Multiple randomized trials, large cohort studies, and meta-analyses have not shown that statins or other LDL-lowering therapies increase dementia risk or cause persistent cognitive decline,” says Dr. Alon Gitig, Director of Preventive Cardiology at the Atria Health Institute, “however, many of these studies were not designed with cognition as a primary outcome. Ongoing dedicated trials will further clarify effects.”
Most of these studies followed participants for two to five years, with some extending up to 25 years. Across multiple systematic reviews and meta-analyses, the findings are strikingly consistent: There is no difference in cognitive outcomes — including memory, executive function, or overall cognition — between statin users and non-users. This holds true even among older adults and those taking high doses of statins.
Recently, the largest systematic review and meta-analysis conducted to date evaluated 55 observational studies encompassing a total of 7.7 million people. This study demonstrated the neuroprotective effects of statins. Statin use was associated with a significantly reduced risk of dementia compared to nonusers, for both Alzheimer’s disease and vascular dementia. In addition, longer duration of use (>3 years), and for people with type 2 diabetes mellitus, and populations from Asia, are where the greatest protective effect was observed. Rosuvastatin (a hydrophilic statin) showed a stronger protective effect for all-cause dementia with a risk reduction of 28 percent.
Katie Couric MediaThe Facts About Statins and Dementia Risk"If you’ve spent any time on social media lately, you may have seen alarming posts claiming that statin medications can cause dementia or memory loss due to their cholesterol lowering effects."katiecouric.com


